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Abstract
Nonspecific interstitial pneumonia has been linked to numerous etiologies including, most recently,
haematologic malignancy. We present a 46-year-old woman with recent-onset rheumatologic illness
who developed pulmonary symptoms as the presenting feature of biphenotypic acute leukaemia.
Chest radiology demonstrated bilateral infiltrates, and lung biopsy revealed nonspecific interstitial
pneumonia. Corticosteroid therapy resulted in resolution of both her pulmonary and rheumatologic
symptoms, and her pulmonary symptoms did not recur following treatment of her leukemia. The case
highlights the importance of searching for an underlying etiology when confronted with nonspecific
interstitial pneumonia.
Case presentation
A46-year-oldwomanof Ethiopiandescentpresentedtoour
emergency department with 3 weeks of worsening non-
productive cough, dyspnea, fever, chills and night sweats.
The patient’s medical history was significant for a three-year
history of an uncharacterized rheumatologic illness marked
by myalgias, arthralgias, two episodes of iridocyclitis, and
a positive anti-nuclear antibody titer of 1:160, which had
responded to treatment with systemic corticosteroids. Just
three months prior to this presentation, she had developed
thrombocytopenia with platelets to 37,000/mm
3 which
responded to prednisone (60 mg/day) which was slowly
being tapered. Upon admission, her medications included
prednisone (10 mg/day), calcium, and alendronate. Other
past medical history included hypothyroidism and a
completed treatment course for latent tuberculosis with
isoniazid more than ten years prior. She worked as a cab
driver and had a remote 20 pack-year history of smoking.
She did not use alcohol or illicit drugs, and there was no
family history of respiratory disease.
On examination, her temperature was 102.5 F with heart
rate of 135 beats/minute, respirations of 33 breaths/min
and oxygen saturation of 85% on 2 L/min supplemental
oxygen. She was a moderately ill-appearing woman who
had difficulty speaking in full sentences. Inspiratory
crackles were present in bilateral lung fields and clubbing
was absent. Her chest X-ray revealed diffusely increased
interstitial prominence (Figure 1A). Laboratory evaluation
indicated WBC of 6,700/mm
3 with 16% neutrophils,
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microbiologic studies were negative and bronchoalveolar
lavage was non-diagnostic.
Chest CT showed diffuse patchy pulmonary interstitial
opacities with peripheral predilection showing areas of
septal thickening, ground glass, and subpleural honey-
comb change (Figure 2) with para-aortic adenopathy. An
open lung biopsy of the lingula revealed expansion of the
interstitium by a diffuse lymphoplasmacytic infiltrate,
intra-alveolar histiocytes and moderate interstitial fibrosis
without fibroblastic foci or honeycomb lung (Figure 3).
Immunostains confirmed a polymorphic population of
T and B-lymphocytes with variable degrees of alveolar
filling by benign macrophages with no evidence of
leukemic infiltrates. This suggested a histopathologic
diagnosis of nonspecific interstitial pneumonia.
Because of the patient’s lymphoplasmacytic lung infiltrate,
peripheral blood atypical lymphocytes, and cytopenias,
a bone marrow aspiration and biopsy was conducted to
assess for the possibility of a hematologic malignancy. Her
aspirate revealed 55% blasts with the following immuno-
phenotype by flow cytometry: cytoplasmic CD3+, surface
CD3-, CD7+, CD5+, CD2-, CD1-, CD33+, CD13-, CD117-,
MPO-, CD79a-, CD56-, CD34+, terminal deoxytransferase
(TdT)+, CD10+, CD45 dimly +, consistent with bipheno-
typic acute leukemia.
Given our initial suspicion for respiratory infection in the
setting of chronic immunosuppression, we began treat-
ment with moxifloxacin to cover community acquired
bacterial pneumonia and trimethoprim-sulfamethoxazole
with high-dose prednisone for the possibility of PCP. By
the third day of hospitalization, however, the patient
showed marked improvement in her respiratory symp-
toms without any evidence of infectious etiology and all
antibiotics were withdrawn.
The patient’s respiratory function continued to improve
over a period of five days; supplemental oxygen was
discontinuedandsteroidsweretapered.Twoweeksafterher
presentationshereceivedstandardinductionchemotherapy
for AML consisting of daunorubicin 60 mg/m
2 by intra-
venous push for three days and cytarabine 200 mg/m
2/day
by continuous infusion for seven days. Her day 14 bone
marrow biopsy revealed an ablated marrow and complete
Figure 1. Chest radiograph showing diffuse, patchy bilateral
interstitial infiltrates.
Figure 2. Chest CT revealing diffuse interstitial lung disease
with septal interstitial thickening.
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underwent matched related donor allogeneic peripheral
blood stem cell transplantation using reduced-intensity
conditioning. There were no respiratory difficulties during
the induction period or at any time following the
transplantation. However, her disease relapsed 157 days
after transplant and she passed away on day 205.
Discussion
The lung pathology confirmed a diagnosis of nonspecific
interstitial pneumonia. Nonspecific interstitial pneumonia
(NSIP) represents a subtype of idiopathic interstitial
pneumonia (IIP) with histologic features distinct from
other IIPs, including varying degrees of cellular interstitial
infiltrate (usually of mononuclear inflammatory cells)
and interstitial fibrosis. NSIP may be seen in patients with
a history of connective tissue diseases, toxic environmental
exposures, drugs, hypersensitivity pneumonitis, infection,
and prior lung injury [1]. Most recently, it has been
reported in association with malignancy including leuke-
mia [2,3]. While the pathogenesis of NSIP is unclear,
both epithelial injury and immune activation have been
implicated [4].
Clinically, patients with NSIP experience slowly progres-
sive dyspnea in addition to other more common
symptoms of chronic nonproductive cough, fatigue,
malaise, anorexia and weight loss, all of which can be
seen in chronic interstitial pulmonary disorders. Physical
exam findings include the presence clubbing in approxi-
mately 10% of patients and bibasilar crackles in virtually
all of them [1]. Laboratory findings are generally
nonspecific but can frequently include an elevated
erythrocyte sedimentation rate and lactate dehydrogenase
level. Like other interstitial disorders, pulmonary function
testing generally shows a decrease in diffusion to carbon
monoxide and restrictive ventilatory deficit as marked by
reductions in total lung capacity, residual volume, and
functional residual capacity.
Chest radiographic findings are frequently nonspecific but
can reveal increased interstitial markings with a basilar
predominance; often high resolution computed tomo-
graphy can be helpful. Bilateral, symmetric ground glass
opacification is seen in about half of cases [5] which may
indicate areas of cellular NSIP that have potential
therapeutic and prognostic implications; presence of
honeycombing and/or other fibrotic structural aberrations
particularly in lower lung zones may indicate more fibrotic
NSIP that may clinically approximate usual interstitial
pneumonitis (UIP) more closely. Thus, despite suggestive
imaging findings, surgical lung biopsy is often necessary
to differentiate NSIP from other interstitial pulmonary
pneumonitides, particularly UIP.
Although the response of IIPs to treatment is variable,
NSIP generally carries a favorable prognosis, particularly
compared to UIP [5]. The initial approach is to treat the
underlying cause, including withdrawal of possible incit-
ing medications or treatment of possible underlying
connective tissue disorders. For patients in whom an
underlying etiology cannot be found or who do not
respond to this initial approach, corticosteroids are the
mainstay of therapy. Immunosupressive drugs such as
azathioprine and cyclophosphamide are an additional
option for patients with more severe disease or who have
an inadequate response to corticosteroids. According to a
recent review, 10-year survival for patients with NSIP is
73.2% [5] and as many as 87% [1] of patients improve or
recover completely.
In our patient, NSIP was likely a paraneoplastic pheno-
menon associated with the patient’s underlying biphe-
noptypic acute leukemia (BAL). BAL is a rare disease
accounting for 3-10% of all acute leukemia [6]. Unlike
myeloid or lymphoid-specific leukemias, BAL cells simul-
taneously coexpress both myeloid and lymphoid antigens.
There is little evidence to guide the therapy of BAL and
regimens for acute myeloblastic leukemia and acute
Figure 3. Low-power magnification (hematoxylin-eosin,
original × 50) of lung biopsy showing expansion of the
interstitium by inflammation and fibrosis. Inset: High-power
magnification (hematoxylin-eosin, original × 400)
demonstrating diffuse cellular interstitial pneumonitis with
prominent lymphoplasmacytic infiltrates and intra-alveolar
filling by histiocytes.
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although she had bone marrow and circulating blasts, her
lung infiltrates were comprised of lymphoplasmacytes and
polytypic lymphocytes rather than large cells consistent
with myelolymphoblasts, suggesting a paraneoplastic
process rather than simple leukemic cell infiltration.
Paraneoplastic autoimmune phenomena that include
pulmonary infiltrates have been associated with a variety
of hematologic disorders including myelodysplastic
syndrome, chronic myelomonocytic leukemia, chronic
lymphocytic leukemia, and lymphoma [8,9]. Although
pulmonary infiltrates have not been reported in associa-
tion with BAL prior to this case, autoimmune phenomena
including pyoderma gangrenosum and osteoarthralgia
have been associated with BAL [10].
In this patient, bronchoalveolar lavage and microbiologic
studies did not disclose other causes for her NSIP. In
addition, her symptoms promptly resolved with cortico-
steroid treatment and did not recur following treatment
for leukemia. Although these findings do not definitively
support a causative role of BAL, they are consistent with
the notion that NSIP may represent a paraneoplastic
process in some patients with underlying myelo/lympho-
proliferative disorders.
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